Review
[Estrogens, progestins and the bone]
[Article in
French]
Affiliations
- PMID: 8146561
Item in Clipboard
Review
[Estrogens, progestins and the bone]
[Article in
French]
Rev Prat.
.
Abstract
Estrogens are the most effective agents in the prevention of post-menopausal osteoporosis, as witnessed by numerous epidemiological and clinical studies. They inhibit bone resorption by complex mechanisms, modulating the action of calciotropic hormones and facilitating the production by bone cells of proteinic factors (cytokines, bone growth factor). Recent studies suggest that estrogens might also stimulate bone formation directly. Moreover, synthetic progestins are thought to have a trophic effect on bone tissue. The effectiveness and excellent metabolic tolerance of the available compounds should widen the indications of replacement therapy in postmenopause.
Similar articles
-
Prevention and treatment of osteoporosis with hormone replacement therapy.Int J Fertil Menopausal Stud. 1993;38 Suppl 1:45-54. Int J Fertil Menopausal Stud. 1993. PMID: 8499959 Review.
-
Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.J Endocrinol Invest. 2005;28(10 Suppl):80-4. J Endocrinol Invest. 2005. PMID: 16550729 Review.
-
Comparative cardiovascular effects of different progestins in menopause.Int J Fertil Womens Med. 2001 Sep-Oct;46(5):248-56. Int J Fertil Womens Med. 2001. PMID: 11720197 Review.
-
[Prevention of osteoporosis using estrogen and gestagens].Gynakologe. 1992 Feb;25(1):31-5. Gynakologe. 1992. PMID: 1547979 Review. German. No abstract available.
-
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.CMAJ. 1996 Oct 1;155(7):929-34. CMAJ. 1996. PMID: 8837542 Free PMC article. Review.